BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions with no assurance regarding timing, size, or terms.
The company plans to use the net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Proposed Public Offering
BioSig intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds will be used for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- BioSig's decision to issue shares through a public offering indicates a strategic move to raise capital for specific purposes.
- The involvement of Clear Street and Needham & Company as book-running managers adds credibility to the offering process.
The public offering by BioSig Technologies Inc. reflects a strategic approach to financial growth and market expansion, aligning with the company's investment policy and corporate objectives.